Advertisement
HAE ข่าวฟอเร็กซ์
Haemonetics Agrees To Buy OpSens In $253 Mln All-cash Deal
Medical technology company Haemonetics Corp. (HAE) and OpSens, Inc. (OPS.TO, OPSSF.PK) announced Tuesday that they have entered into a definitive agreement under which Haemonetics will acquire all outstanding shares of OpSens for C$2.90 per share in an all-cash transaction representing a fully diluted equity value of approximately $253 million at current exchange rate.
RTTNews
|
671 วันที่ผ่านมา
